Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1017459)
Received: 7 February 2018
Accepted: 2 July 2018
First Online: 11 July 2018
Ethics approval and consent to participate
: All patients provided written consent to any data and samples collected as part of the trial being used in further studies to improve the diagnosis and treatment of tuberculosis, as stated on the informed consent form for the study. Ethics approval was granted for REMoxTB by the ethics board at University College London, and at each of the study sites:KenyaUnorderedList removedSouth AfricaUnorderedList removedTanzaniaUnorderedList removedZambiaUnorderedList removedChinaUnorderedList removedIndiaUnorderedList removedMexicoUnorderedList removedThailandUnorderedList removedMalaysiaUnorderedList removed
: Not applicable.
: The authors’ declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.